Harvard Medical School and Brigham and Women’s Hospital are recommending 31 papers authored by a former lab director be retracted from medical journals, STAT reported this week.

In spite of recent research suggesting statins might carry some benefit for non-CVD patients, a review published in the Annals of Internal Medicine this week concluded they have no role outside of heart disease and could, in some cases, even increase patients’ risk for diabetes and myopathy.

A group of young cardiologists in New York City is opening hybrid health clinics, which combine the in-person guidance of physicians with the latest in digital health technology and screening tools.

A machine learning tool developed by researchers at Michigan State University can accurately predict an individual’s height within an inch and may offer more precise CVD and cancer risk assessment in the future, according to a report featured this month in Genetics.

Some cardiologists at TCT 2018 worried negative posts about ongoing trials could affect patient enrollment, while others encouraged more colleagues to join social media discussions so the medical community can better quash misinformation.

The Detroit Medical Center removed three cardiologists from leadership positions and another resigned over what the hospital system says are conduct violations but the doctors say is punishment for raising concerns about patient safety and quality of care.

Abbott has received a CE mark for its High Sensitive Troponin-I test—a diagnostic test designed to predict heart disease even in patients without cardiac symptoms—the company announced this week.

A New Jersey hospital is testing an artificial intelligence (AI) device designed to alert clinicians to bleeding episodes during endovascular procedures.